To: | Hy-Vee, Inc. (tzarley@zarleylaw.com) |
Subject: | U.S. Trademark Application Serial No. 90051432 - VIVID CLEAR RX - T62649US0 |
Sent: | September 14, 2020 12:07:59 PM |
Sent As: | ecom106@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 90051432
Mark: VIVID CLEAR RX
|
|
Correspondence Address: |
|
Applicant: Hy-Vee, Inc.
|
|
Reference/Docket No. T62649US0
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: September 14, 2020
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by Timothy Zarley on 9/14/2020, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods and/or services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and/or services are not permitted. 37 C.F.R. §2.71(a).
DISCLAIMER REQUIREMENT
The following disclaimer statement is added to the record:
No claim is made to the exclusive right to use “RX” apart from the mark as shown.
See 15 U.S.C. §1056(a); TMEP §§1213, 1213.03(c), 1213.08(a)(i).
/Samir Ramesh-Patel/
Samir Ramesh-Patel
Examining Attorney
Law Office 106
(571) 272-6699
samir.ramesh-patel@uspto.gov